EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Reduction in Weekly Urticaria Activity Score (UAS7) With Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 Dose-Ranging Study

Saturday 01 Jun, 13:43 PM - 13:50 PM Valencia, Spain